AstraZeneca Receives Over $1B In BARDA Funding For Coronavirus Vaccine

AstraZeneca plc (NYSE: AZN), which is collaborating with the Oxford University to develop a vaccine for SARS-CoV-2, announced Thursday a funding commitment from the U.S. Biomedical Advanced Research and Development Authority and also unveiled manufacturing plans. BARDA Extends Over $1B In Funding The U.K.-based, large-cap biopharma, which is one of the best-performing companies in the space this year, said it has received a funding commitment of…